{"transactions":[{"id":912512,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":67081,"kind":"person","name":"SANDS ARTHUR T","position":1,"cik":"0001134106","reported_name":"SANDS ARTHUR T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-10T17:43:09.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":562500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/36 of the total shares monthly beginning March 10, 2026, until the option is fully vested on February 9, 2029, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":562500,"derivative":{"exercise_price":16.45,"expiration_date":"2036-02-09","underlying":"Common Stock","underlying_shares":562500},"source":{"system":"sec-edgar","filing":"0001134106-26-000002","document":"wk-form4_1770763386.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134106/000113410626000002/wk-form4_1770763386.xml","form_type":"4"}},{"id":1269974,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":67081,"kind":"person","name":"SANDS ARTHUR T","position":1,"cik":"0001134106","reported_name":"SANDS ARTHUR T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-13T16:12:35.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/36 of the total shares monthly beginning March 11, 2025, until the option is fully vested on February 10, 2028, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":450000,"derivative":{"exercise_price":17.12,"expiration_date":"2035-02-10","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001549595-25-000035","document":"wk-form4_1739481148.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134106/000154959525000035/wk-form4_1739481148.xml","form_type":"4"}},{"id":1641434,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":67081,"kind":"person","name":"SANDS ARTHUR T","position":1,"cik":"0001134106","reported_name":"SANDS ARTHUR T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-15T07:22:51.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/36 of the total shares monthly beginning March 13, 2024, until the option is fully vested on February 13, 2027, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":800000,"derivative":{"exercise_price":8.72,"expiration_date":"2034-02-12","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001549595-24-000017","document":"wk-form4_1707999761.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134106/000154959524000017/wk-form4_1707999761.xml","form_type":"4"}},{"id":2013894,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":67081,"kind":"person","name":"SANDS ARTHUR T","position":1,"cik":"0001134106","reported_name":"SANDS ARTHUR T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-15T16:12:15.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":448000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/36 of the total shares monthly beginning March 14, 2023 until the option is fully vested on February 14, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":448000,"derivative":{"exercise_price":10.83,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":448000},"source":{"system":"sec-edgar","filing":"0001209191-23-009710","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134106/000120919123009710/doc4.xml","form_type":"4"}},{"id":2189837,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":67081,"kind":"person","name":"SANDS ARTHUR T","position":1,"cik":"0001134106","reported_name":"SANDS ARTHUR T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-08-10T16:16:48.000Z","date":"2022-08-09","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/48 of the total shares monthly beginning September 9, 2022 until the option is fully vested on August 9, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":400000,"derivative":{"exercise_price":18.5,"expiration_date":"2032-08-08","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001209191-22-045194","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134106/000120919122045194/doc4.xml","form_type":"4"}},{"id":2428971,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":67081,"kind":"person","name":"SANDS ARTHUR T","position":1,"cik":"0001134106","reported_name":"SANDS ARTHUR T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-01-21T16:25:53.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/48 of the total shares monthly beginning February 20, 2022 until the option is fully vested on January 20, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":300000,"derivative":{"exercise_price":18.89,"expiration_date":"2032-01-19","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-22-004433","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134106/000120919122004433/doc4.xml","form_type":"4"}},{"id":2863962,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":67081,"kind":"person","name":"SANDS ARTHUR T","position":1,"cik":"0001134106","reported_name":"SANDS ARTHUR T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-02-12T19:24:08.000Z","date":"2021-02-11","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/48 of the total shares monthly beginning March 11, 2021 until the option is fully vested on February 11, 2025, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":150000,"derivative":{"exercise_price":38.97,"expiration_date":"2031-02-10","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-21-010442","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134106/000120919121010442/doc4.xml","form_type":"4"}},{"id":3000867,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":67081,"kind":"person","name":"SANDS ARTHUR T","position":1,"cik":"0001134106","reported_name":"SANDS ARTHUR T","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-23T17:22:51.000Z","date":"2020-10-21","kind":"grant","acquired":true,"shares":804170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/48 of the total shares monthly beginning August 23, 2020 until the option is fully vested on July 23, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":804170,"derivative":{"exercise_price":26.91,"expiration_date":"2030-10-20","underlying":"Common Stock","underlying_shares":804170},"source":{"system":"sec-edgar","filing":"0001209191-20-055716","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134106/000120919120055716/doc4.xml","form_type":"4"}}]}